1. News | 2014.12.03

   MATI (Morocco, Algeria, Tunisia and Iran) Regional Meeting from 24th to 26th November 2014

   The regional MATI meeting was organized in Casablanca by the Institut Pasteur in Morocco. This meeting provided a unique opportunity for researchers from MATI region and also for visiting researchers from the Hellenic and Dakar Institut Pasteur to share, compare their knowledge / scientific experiences and to explore new areas specific to the MATI region for cooperation in the areas of health....

2. News | 2014.12.03

   Institut Pasteur Graduation Ceremony 2014

   The Institut Pasteur will host on the 12th of December 2014  the 2nd ceremony in honor of its graduating PhD class, with the  Doctors having defended in 2013-2014. This ceremony will be chaired by Pr Christian Bréchot, President of the Institut Pasteur. It will be held in presence of Jean-Philippe Pierre, deputy mayor of the 15th arrondissement of Paris.

3. News | 2015.01.19

   All about Ebola at the Institut Pasteur

   Since the beginning of the Ebola outbreak that is currently raging in Wet Africa, the Institut Pasteur, both in Paris and through its international network, has played an active role, applying its expertise to help contain the virus. Further information and all lastest news about the Institut Pasteur's involvement in the Ebola response can be found there.

4. News | 2014.12.04

   Scientific collaboration with Myanmar

   The arrival in Myanmar of Mrs Annick Girardin, Minister of State for Development and Francophonie was an opportunity to formalize the scientific collaboration between the Institut Pasteur, the Institut Pasteur International Network and the National Health Laboratory (NHL) in Rangoon. The partnership will strengthen the capacity of the NHL on two levels: the fight against acute respiratory...

5. News | 2014.12.11

   Malaria: formal identification of the artemisinin resistance gene

   Together with teams from Columbia University (USA), CNRS in Toulouse and NIH/NIAID (USA), Institut Pasteur scientists based in Paris and Cambodia have recently provided the key demonstration that K13 is indeed the main determinant of artemisinin resistance in Plasmodium falciparum parasites. This work is a landmark for the scientific community, as it provides a validated molecular marker for...

6. News | 2013.12.18

   Molecular marker discovered for detecting artemisinin-resistant forms of malaria

   Scientists at the Institut Pasteur in Paris and Cambodia, CNRS and NIH have identified a molecular marker for detecting malaria parasites with resistance to artemisinin derivatives Un marqueur moléculaire permettant de détecter les parasites du paludisme résistants aux dérivés de l’artémisinine, constituants majeurs des traitements antipaludiques actuellement recommandés par l’OMS, a...

7. News | 2013.12.12

   A prime target for the development of anti-inflammatories

   For the first time, scientists from the Institut Pasteur and Inserm have demonstrated the key role played by a particular molecule in intestinal infection.

8. News | 2013.12.11

   Carriers of a genetic mutation show increased dependence on tobacco

   Scientists at the Institut Pasteur, the French National Center for Scientific Research (CNRS) and Pierre and Marie Curie University (UPMC) have recently proven that, in mice, nicotine intake – nicotine is the main addictive substance in tobacco – is heavily regulated by a genetic mutation that is very common in humans. 

9. News | 2013.11.03

   Identification of a new mechanism in immunotherapy for lymphoma

   Using innovative dynamic imaging technique, scientists at the Institut Pasteur, Inserm and the VU Medical Center in Amsterdam have uncovered the mode of action of anti-CD20, an antibody therapy frequently used in the treatment of lymphomas (cancers of the immune system) as well as some auto-immune diseases. In a lymphoma model, the scientists have been able to carry out real time in vivo imaging...

10. News | 2013.11.04

    Two European programs reinforce the fight against emerging diseases

    The 31 partners involved in the two major European research programs PREDEMICS and ANTIGONE are to meet for a joint seminar at the Institut Pasteur on November 6th. These two programs will respectively receive €11.7 million and €12 million funding of the European Union over five years to study the emergence mechanisms of infectious diseases in order to strengthen existing treatment and...

Pages